Nu Skin Enterprises (NYSE:NUS – Get Free Report) updated its fourth quarter 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 0.190-0.290 for the period, compared to the consensus earnings per share estimate of 0.200. The company issued revenue guidance of $410.0 million-$445.0 million, compared to the consensus revenue estimate of $441.0 million. Nu Skin Enterprises also updated its FY 2024 guidance to 0.650-0.750 EPS.
Nu Skin Enterprises Stock Up 1.6 %
NUS stock traded up $0.10 during mid-day trading on Friday, hitting $6.55. 991,684 shares of the company were exchanged, compared to its average volume of 751,884. Nu Skin Enterprises has a twelve month low of $5.95 and a twelve month high of $20.75. The company has a current ratio of 2.12, a quick ratio of 1.33 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $325.54 million, a PE ratio of -2.20 and a beta of 1.14. The firm has a fifty day simple moving average of $6.85 and a 200 day simple moving average of $9.87.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The business had revenue of $439.10 million during the quarter, compared to the consensus estimate of $431.87 million. During the same period in the previous year, the company posted $0.54 earnings per share. The firm’s revenue for the quarter was down 12.2% on a year-over-year basis. On average, research analysts forecast that Nu Skin Enterprises will post 0.78 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
Analyst Ratings Changes
A number of research firms recently weighed in on NUS. Citigroup lowered their price target on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a report on Tuesday, October 22nd. StockNews.com lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Wednesday, October 23rd. Finally, DA Davidson dropped their price objective on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th.
View Our Latest Analysis on NUS
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
- Five stocks we like better than Nu Skin Enterprises
- How to Effectively Use the MarketBeat Ratings Screener
- California Resources Stock Could Be a Huge Long-Term Winner
- Options Trading – Understanding Strike Price
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- The Risks of Owning Bonds
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.